Telepsychiatry for Substance Use Disorders: Evolution from Rapid COVID-19 Pandemic Adoption to Sustainable Integration
Marshall Journal of Medicine · 31.10.2025 · 11 (4)
DOI: 10.33470/2379-9536.1502 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marshall Journal of Medicine, online erschienen am 31.10.2025. Verfasst von Jack Wang. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Prior to the COVID-19 pandemic, telepsychiatry for substance use disorder (SUD) management was generally an underutilized modality, mainly due to regulatory constraints. Through the pandemic, governmental deregulations rapidly and massively expanded their adoption, bringing out their significant potential to expand access, overcome barriers, and mitigate stigma for individuals seeking addiction care, particularly for rural and underserved populations. This narrative review consolidates the recent research on the growing adoption of telepsychiatry in the management of SUDs. It aims to explore the evidence-based benefits, identify common challenges, and underscore key considerations for its effective and equitable integration into SUD treatment paradigms.
Method
This review examines telemental health and SUD literature published between 2010 and 2025. We searched Google Scholar, MEDLINE, and EBM Reviews using keywords such as "telepsychiatry," "addiction," and "veteran." Only complete, English-language studies were included. Articles underwent a two-phase screening: first by title and abstract for relevance, then by full-text review against inclusion criteria. The analysis employed mixed methods, combining interpretive synthesis of qualitative data (barriers, accessibility) with quantitative analysis of adoption rates. Statistical analysis was performed using Python for Chi-square tests and data visualization.
Results
Telepsychiatry provides substantial advantages for SUD care, with the most significant being expanded access for rural and underserved populations; in addition, it reduces patients’ costs, transit burdens, and stigma, which improves treatment initiation and retention. It has demonstrated value across various SUD interventions, such as medications for opioid use disorder (MOUD) initiation and maintenance, individual and group psychotherapy, and psychiatric evaluations. However, implementation faces obstacles related to the digital divide, navigating evolving regulatory and reimbursement landscapes, and effectively managing acute or highly complicated cases remotely. The literature suggests that an integrated approach, combining virtual and in-person visits, may offer greater outcomes.
Discussion
While not a panacea, telepsychiatry is an integral tool that can significantly improve the accessibility and continuity of care for the SUD population. Its effective and enduring implementation calls for further research to examine its long-term outcomes, patient-centered approaches for diverse populations, and the development of supportive policy frameworks to ensure quality and equitable care.
Zitieren
APA
Wang, J. (2025). Telepsychiatry for Substance Use Disorders: Evolution from Rapid COVID-19 Pandemic Adoption to Sustainable Integration. Marshall Journal of Medicine, 11(4). https://doi.org/10.33470/2379-9536.1502
Vancouver
Wang J. Telepsychiatry for Substance Use Disorders: Evolution from Rapid COVID-19 Pandemic Adoption to Sustainable Integration. Marshall Journal of Medicine. 2025;11(4). doi:10.33470/2379-9536.1502
BibTeX
@article{Wang2025,
author = {Wang, Jack},
title = {Telepsychiatry for Substance Use Disorders: Evolution from Rapid COVID-19 Pandemic Adoption to Sustainable Integration},
journal = {Marshall Journal of Medicine},
year = {2025},
volume = {11},
number = {4},
doi = {10.33470/2379-9536.1502}
}
EUVIMED